Pfizer Inc is planning to acquire India's Agila Specialties, the injectable-medicines unit of Indian drug supplier Strides Arcolab Ltd, for a possible price of $2 bn, according to reports.
Reports stated that the deal could be reached this quarter.
Agila makes cancer treatments and antibiotics.
India Infoline Research Team / 14:59, May 20, 2015
GPIL reported 13.5% yoy decline in operating profit as the impact of higher volumes was offset by lower product prices